ALPHATEC HOLDINGS, INC. Other Operating Activities, Cash Flow Statement
ALPHATEC HOLDINGS, INC. (ATEC) reported Other Operating Activities, Cash Flow Statement of $2.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherOperatingActivitiesCashFlowStatement · last filed 2026-08-04
- ALPHATEC HOLDINGS, INC. other operating activities, cash flow statement for the quarter ending 2026-06-30 was $1.00M.
- ALPHATEC HOLDINGS, INC. other operating activities, cash flow statement for the quarter ending 2026-03-31 was $1.13M, a 73.49% decline year-over-year.
- ALPHATEC HOLDINGS, INC. other operating activities, cash flow statement for the quarter ending 2025-12-31 was $2.79M, a 1285.57% increase year-over-year.
- ALPHATEC HOLDINGS, INC. other operating activities, cash flow statement for the quarter ending 2025-09-30 was $1.46M, a 29000.00% increase year-over-year.
- ALPHATEC HOLDINGS, INC. other operating activities, cash flow statement for fiscal 2025 was $8.39M, a 61.49% increase from fiscal 2024.
- ALPHATEC HOLDINGS, INC. other operating activities, cash flow statement for fiscal 2024 was $5.19M, a 1041.54% increase from fiscal 2023.
- ALPHATEC HOLDINGS, INC. other operating activities, cash flow statement for fiscal 2023 was $455.00K, a 61.67% decline from fiscal 2022.
- ALPHATEC HOLDINGS, INC. other operating activities, cash flow statement for fiscal 2022 was $1.19M, a 56.38% decline from fiscal 2021.
| Period end | Other Operating Activities, Cash Flow Statement 3 month | Other Operating Activities, Cash Flow Statement 6 month | Other Operating Activities, Cash Flow Statement 6 month as first filed | Other Operating Activities, Cash Flow Statement 9 month | Other Operating Activities, Cash Flow Statement 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.13M 10-Q · filed 2026-08-04 | $4.91M derived: sum of 3 quarters · filed 2026-08-04 | $6.37M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $1.13M 10-Q · filed 2026-05-05 | $3.91M derived: sum of 2 quarters · filed 2026-05-05 | $5.37M derived: sum of 3 quarters · filed 2026-05-05 | $5.26M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $4.24M derived: sum of 2 quarters · filed 2026-02-24 | $4.14M derived: sum of 3 quarters · filed 2026-08-04 | $8.39M 10-K · filed 2026-02-24 | |
| 2025-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.35M derived: sum of 2 quarters · filed 2026-08-04 | $5.60M 10-Q · filed 2025-10-30 | $5.80M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | -$104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $4.15M 10-Q · filed 2026-08-04 | $4.35M derived: sum of 3 quarters · filed 2026-08-04 | $4.35M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $4.25M 10-Q · filed 2026-05-05 | $4.45M derived: sum of 2 quarters · filed 2026-05-05 | $4.46M derived: sum of 3 quarters · filed 2026-05-05 | $7.79M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $201.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $206.00K derived: sum of 2 quarters · filed 2026-02-24 | $3.54M derived: sum of 3 quarters · filed 2026-02-24 | $5.19M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.34M derived: sum of 2 quarters · filed 2025-10-30 | $4.99M 10-Q · filed 2025-10-30 | $3.73M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $3.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $4.99M 10-Q · filed 2025-07-31 | $3.73M derived: sum of 3 quarters · filed 2026-02-24 | $4.58M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $1.66M 10-Q · filed 2025-05-01 | $393.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.25M derived: sum of 3 quarters · filed 2026-02-24 | $1.52M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$405.00K derived: sum of 2 quarters · filed 2026-02-24 | -$135.00K derived: sum of 3 quarters · filed 2026-02-24 | $455.00K 10-K · filed 2026-02-24 | |
| 2023-09-30 | $857.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $1.13M derived: sum of 2 quarters · filed 2024-10-30 | $1.72M 10-Q · filed 2024-10-30 | $2.33M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $860.00K 10-Q · filed 2024-07-31 | $1.47M derived: sum of 3 quarters · filed 2025-02-26 | $2.17M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $590.00K 10-Q · filed 2024-05-07 | $1.20M derived: sum of 2 quarters · filed 2025-02-26 | $1.90M derived: sum of 3 quarters · filed 2025-02-26 | $2.02M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.31M derived: sum of 2 quarters · filed 2025-02-26 | $1.43M derived: sum of 3 quarters · filed 2025-02-26 | $1.19M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $699.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $816.00K derived: sum of 2 quarters · filed 2023-11-06 | $573.00K 10-Q · filed 2023-11-06 | $2.43M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$126.00K 10-Q · filed 2023-08-03 | $1.73M derived: sum of 3 quarters · filed 2024-02-27 | $592.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | -$243.00K 10-Q · filed 2023-05-04 | $1.62M derived: sum of 2 quarters · filed 2024-02-27 | $475.00K derived: sum of 3 quarters · filed 2024-02-27 | $2.18M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $718.00K derived: sum of 2 quarters · filed 2024-02-27 | $2.42M derived: sum of 3 quarters · filed 2024-02-27 | $2.72M 10-K · filed 2024-02-27 | |
| 2021-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $562.00K derived: sum of 2 quarters · filed 2022-11-03 | $861.00K 10-Q · filed 2022-11-03 | $898.00K derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.00M 10-Q · filed 2022-08-04 | $1.99M 10-Q · filed 2021-08-03 | $2.04M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2021-03-31 | $299.00K 10-Q · filed 2022-05-05 | $336.00K derived: sum of 2 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $116.00K 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $79.00K 10-Q · filed 2021-11-04 | ||||
| 2015-12-31 | -$4.36M 10-K · filed 2016-03-15 | ||||
| 2014-12-31 | $1.91M 10-K · filed 2016-03-15 | ||||
| 2013-12-31 | $1.46M 10-K · filed 2016-03-15 | ||||
| 2013-03-31 | $285.00K 10-Q · filed 2013-05-02 | $553.00K derived: sum of 2 quarters · filed 2015-02-27 | $1.34M derived: sum of 3 quarters · filed 2015-02-27 | $2.20M derived: sum of 4 quarters · filed 2015-02-27 | |
| 2012-12-31 | $268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $1.06M derived: sum of 2 quarters · filed 2015-02-27 | $1.92M derived: sum of 3 quarters · filed 2015-02-27 | $2.16M 10-K · filed 2015-02-27 | |
| 2012-09-30 | $792.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.65M derived: sum of 2 quarters · filed 2012-11-06 | $1.89M 10-Q · filed 2012-11-06 | ||
| 2012-06-30 | $856.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $1.10M 10-Q · filed 2012-08-08 | |||
| 2012-03-31 | $242.00K 10-Q · filed 2013-05-02 | ||||
| 2011-12-31 | $0.00 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |